Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

1681.HK Gross Margin

The Gross Margin of Consun Pharmaceutical Group Ltd (1681.HK) is 75.56%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

1681.HK Gross Margin - Historical Value
Date Value
2024-12-31 75.56%
2023-12-31 74.19%
2022-12-31 75.35%
2021-12-31 74.70%
2020-12-31 75.40%
2019-12-31 72.99%
2018-12-31 75.08%
2017-12-31 73.99%
2016-12-31 74.46%
2015-12-31 80.68%
1681.HK Gross Margin - Peers Comparison
Ticker Name Value
300147.SZ Xiangxue Pharmaceutical Co Ltd 32.33%
000908.SZ Hunan Jingfeng Pharmaceutical Co Ltd 69.96%
002550.SZ Changzhou Qianhong Biopharma Co Ltd 42.61%
002940.SZ Zhejiang Anglikang Pharmaceutical Co Ltd 43.80%
300039.SZ Shanghai Kaibao Pharmaceutical Co Ltd 80.44%
600513.SS Jiangsu Lianhuan Pharmaceutical Co Ltd 48.02%
002900.SZ Harbin Medisan Pharmaceutical Co Ltd 59.93%
003020.SZ Hefei Lifeon Pharmaceutical Co Ltd 51.00%
002349.SZ Jinghua Pharmaceutical Group Co Ltd 48.33%
300255.SZ Hebei Changshan Biochemical Pharmaceutical Co Ltd -22.28%
002872.SZ Tiansheng Pharmaceutical Group Co Ltd 45.17%
002923.SZ Zhuhai Rundu Pharmaceutical Co Ltd 47.24%
300194.SZ Fuan Pharmaceutical Group Co Ltd 52.71%
503.HK Lansen Pharmaceutical Holdings Ltd 67.57%
600222.SS Henan Taloph Pharmaceutical Stock Co Ltd 25.76%
600285.SS Henan Lingrui Pharmaceutical Co Ltd 73.26%
000766.SZ Tonghua Golden-Horse Pharmaceutical Industry Co Ltd 74.13%
002365.SZ Qianjiang Yongan Pharmaceutical Co Ltd 19.79%
600976.SS Jianmin Pharmaceutical Group Co Ltd 47.71%
000915.SZ Shandong WIT Dyne Health Co Ltd 83.80%
000919.SZ Jinling Pharmaceutical Co Ltd 18.44%
600351.SS Yabao Pharmaceutical Group Co Ltd 57.50%
600613.SS Shanghai Shenqi Pharmaceutical Investment Management Co Ltd 49.93%
002688.SZ Jinhe Biotechnology Co Ltd 28.72%
300110.SZ Huaren Pharmaceutical Co Ltd 42.53%
600200.SS JiangSu WuZhong Pharmaceutical Development Co Ltd 24.20%
600624.SS Shanghai Fudan Forward S&T Co Ltd 42.73%
002393.SZ Tianjin Lisheng Pharmaceutical Co Ltd 54.00%